TickerFacts.

PharmaCyte Biotech, Inc. (PMCB): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2016-04-30, while the company's latest annual report covers the year ended 2026-04-30. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2016-04-30
$32.1K2011-04-30: $32.1K2012-04-30: $19.4K2013-04-30: $9.6K2014-04-30: $02015-04-30: $02016-04-30: $0$0
2011-04-30 Cost of Revenue (USD) 2016-04-30
Period endedCost of RevenueChange YoYSource filing
2016-04-30$0n/a2016-07-29, From 2015-05-01
2015-04-30$0n/a2016-07-29, From 2014-05-01
2014-04-30$0-100.0%2016-07-29, From 2013-05-01
2013-04-30$9.6K-50.4%2016-01-19, From 2012-05-01
2012-04-30$19.4K-39.6%2013-07-29, From 2011-05-01
2011-04-30$32.1Kn/a2012-08-14, From 2010-05-01